Tuesday, June 15, 2021 3:54:10 PM
The grieving mother of a 32-year-old man who recently died less than 24 hours after receiving the experimental Johnson & Johnson COVID-19 vaccine is issuing an urgent warning to others.
The woman is ringing the alarm bells, saying, “My name is Pamela Goodman and my 32-year-old stepson Benjamin was killed by the Johnson & Johnson vaccine on March 14th, 2021.
“Within 12 hours he was dead of a cardiac arrest… sudden death. We don’t want anyone else to die. Benjamin wouldn’t want anyone else to die,” she continued.
Pamela also said the autopsy provided was inconclusive and that the medical examiner is avoiding the family’s phone calls while refusing to share a toxicology report.
“The mainstream media is not reporting these deaths, these serious adverse reactions,” the mother added. “We can’t bring Benjamin back and this is not only about Benjamin, this is about all of humanity. Benjamin would not ever want anyone to take an experimental vaccine that could cause death or permanent injury.”
The parents say if the media didn’t hide information about the dangers of the experimental vaccines, more people would be hesitant to take the jab.
Benjamin had more reason than most to be reluctant when it came to the vaccine as his mother noted on Facebook, “Ben knew our family history with vaccines.”
“But everyone has been pushing the experimental travel pass,” she explained.
The mother continued to detail Benjamin’s vaccine experience timeline.
On Saturday, he went into a Walgreens and got the vaccine and soon had a bad headache.
Feeling ill, he went to sleep and woke up to a severe fever and chills at 1am.
At 4am, Benjamin’s fiancée woke up to the recently-vaccinated man having a seizure and called 911.
Ben went into cardiac arrest and medics tried to revive him at his apartment and at the hospital.
He was declared dead at 6:05 am, 12 hours after getting vaccinated.
In a call to action, Pamela Goodman told Americans, “This is horrific, this is criminal, this is murder and people need to wake up and speak out.”
Recent JNJ News
- Form 13F-HR - Quarterly report filed by institutional managers, Holdings • Edgar (US Regulatory) • 05/10/2024 09:14:19 PM
- Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • Business Wire • 05/08/2024 08:30:00 PM
- Shockwave Medical Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/06/2024 08:05:00 PM
- Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization • Business Wire • 05/01/2024 10:30:00 AM
- Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC) • Business Wire • 04/22/2024 08:30:00 PM
- Paramount’s Shares Surge Following Sony and Apollo’s Joint Bid; ISS Backs Berkshire Hathaway Director Re-election, and More • IH Market News • 04/19/2024 11:31:22 AM
- US Index Futures See Gains, Oil Prices Dip • IH Market News • 04/17/2024 10:59:02 AM
- U.S. Stocks Finish Lackluster Session Narrowly Mixed • IH Market News • 04/16/2024 08:33:00 PM
- CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results • Business Wire • 04/16/2024 02:46:00 PM
- J&J’s Q1 2024 sales rise 2.3% to $21.4 billion • IH Market News • 04/16/2024 01:52:44 PM
- Dow Looks To Snap Six-Day Losing Streak As UnitedHealth Surges • IH Market News • 04/16/2024 01:09:47 PM
- U.S. Index Futures Signal Mixed Trading, Oil Prices Dip • IH Market News • 04/16/2024 11:19:33 AM
- Ericsson Soars with 66% Net Profit Growth; Live Nation Under Antitrust Scrutiny in US, and More News • IH Market News • 04/16/2024 11:18:19 AM
- Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2% • Business Wire • 04/16/2024 10:25:00 AM
- Johnson & Johnson Reports Q1 2024 Results • Business Wire • 04/16/2024 10:20:00 AM
- U.S. Stocks Extend Sell-Off As Treasury Yields Surge After Retail Sales Data • IH Market News • 04/15/2024 08:38:32 PM
- Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference • Business Wire • 04/08/2024 10:06:00 PM
- CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy • PR Newswire (US) • 04/06/2024 03:21:00 AM
- Rowley Law PLLC is Investigating Proposed Acquisition of Shockwave Medical, Inc. • PR Newswire (US) • 04/05/2024 06:55:00 PM
- Apple Terminates 614 Employees, Disney Unveils June Crackdown on Password Sharing, and More Updates • IH Market News • 04/05/2024 11:38:57 AM
- Johnson & Johnson to Acquire Shockwave Medical • Business Wire • 04/05/2024 10:31:00 AM
- Johnson & Johnson Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation • Business Wire • 04/04/2024 10:01:00 PM
- Johnson & Johnson to Participate in the BofA Securities Health Care Conference • Business Wire • 04/02/2024 08:30:00 PM
- Walgreens Slashes Annual Profit Forecast; MillerKnoll Nosedives 17% on Bleak 4Q Outlook, and Latest News • IH Market News • 03/28/2024 01:48:04 PM
- GameStop Shares Tumble 20% in Pre-Market Trading Amid Revenue Decline, Direct Digital Plummets 42%, and More News • IH Market News • 03/27/2024 10:54:47 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM